netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 6 of 6


Details
LDL Link Added : NICE TA585: Ocrelizumab for treating primary progressive multiple sclerosis : https://www.nice.org.uk/guidance/ta585
06/07/2023 14:19:19
(rpaylor )
UPD sitematrix Changed from 0 to
27/07/2022 08:30:29
(LoweryM )
UPD FurtherInformation Changed from

  • Approved for the treatment of relapsing-remitting multiple sclerosis in line with NICE

     



to
27/07/2022 08:30:29
(LoweryM )
UPD Ocrelizumab (Ocrevus®) formatting
27/07/2022 08:30:29
(LoweryM )
LDL Link Added : NICE TA 533: Ocrelizumab for treating relapsing–remitting multiple sclerosis : https://www.nice.org.uk/guidance/ta533
18/03/2019 15:13:55
(DavidS )
ADD Ocrelizumab (Ocrevus®) added
18/03/2019 15:12:25
(DavidS )

 

 
netFormulary